NCT00256984

Brief Summary

The primary purpose of this study is to determine how effective and how durable STARR (stapled transanal rectal resection) surgery is in relieving symptoms of intractable constipation associated with obstructive defecation syndrome (ODS).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Oct 2005

Typical duration for phase_4

Geographic Reach
1 country

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2005

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 18, 2005

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 22, 2005

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2008

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2008

Completed
2.8 years until next milestone

Results Posted

Study results publicly available

April 7, 2011

Completed
Last Updated

July 16, 2018

Status Verified

October 1, 2017

Enrollment Period

2.4 years

First QC Date

November 18, 2005

Results QC Date

October 27, 2009

Last Update Submit

October 9, 2017

Conditions

Keywords

Obstructive Defecation SyndromeColorectal SurgeryDefecographyConstipationRectoceleIntussusceptionQuality of Life

Outcome Measures

Primary Outcomes (1)

  • Percentage of Change (Reduction) in Total ODS Symptom Composite Score From Baseline to One Year Post Procedure

    The primary endpoint used to assess effectiveness of STARR for treatment of ODS was the percentage of change in total ODS symptom composite score (0=worst, 24=best) 1 year after completion of the procedure.

    one year from Baseline

Secondary Outcomes (6)

  • Percentage of Change in ODS Symptom Composite Score From Baseline at 1 Month Post Procedure

    Baseline, 1 month post procedure

  • Maximum Change in Subject-reported Assessment of Symptom Severity and Frequency (PAC SYM).

    Baseline, 6 months

  • Percentage of Change in ODS Symptom Composite Score From Baseline at 6 Months (0 is Worst Score, 24 is Best Score)

    Baseline, 6 months post procedure

  • PAC QOL Patient Assessment of Constipation (Overall)

    Baseline, 12 months

  • SF-12 QOL Change From Baseline (Physical Component)at 12 Months

    Baseline, 12 Months

  • +1 more secondary outcomes

Interventions

Eligibility Criteria

Age21 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to comprehend, understand, and speak the English language
  • Able to comprehend, follow, and sign an informed consent document (ICD)
  • Able to tolerate general or spinal anesthetic
  • Often experience excessive straining, sense of incomplete evacuation, and/or prolonged time for complete evacuation when attempting a bowel movement
  • Have experienced ODS symptoms for at least 12 months prior to enrollment
  • Have a minimum ODS score of 10
  • Have rectocele and/or rectal intussusception confirmed by defecography
  • Screened for colorectal neoplasia within 7 years of the screening visit (e.g., colonoscopy or barium enema)
  • Have an American Society of Anesthesiologists (ASA) score of no more than 3
  • Willing to comply with evaluation and management schedule through 5-year follow-up

You may not qualify if:

  • Fecal incontinence to solid stool
  • Full-thickness prolapse
  • Perineal infection
  • Recto-vaginal fistula
  • Enterocele (at rest)
  • Any complex pelvic floor prolapse requiring a combined surgical approach
  • Prior sigmoid or anterior resection or prior rectal anastomosis
  • Presence of foreign material adjacent to the rectum (e.g., vaginal mesh)
  • Grade IV hemorrhoids
  • Pregnancy
  • Chronic narcotic use
  • Evidence of colorectal neoplasia, carcinoma, or inflammatory bowel disease
  • Physical or psychological condition which would impair study participation
  • Unable or unwilling to attend follow-up visits and examinations
  • Surgical procedure required concurrently with STARR
  • +6 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Colon and Rectal Clinic of Orlando

Orlando, Florida, 32806, United States

Location

Lahey Clinic

Burlington, Massachusetts, 01805, United States

Location

Colon & Rectal Surgery Associates Ltd.

Minneapolis, Minnesota, 55454, United States

Location

University Hospitals of Cleveland

Cleveland, Ohio, 44106, United States

Location

The Cleveland Clinic Foundation

Cleveland, Ohio, 44195, United States

Location

Medical University of Ohio, Department of Surgery

Toledo, Ohio, 43614, United States

Location

Portland Medical Center

Portland, Oregon, 97205, United States

Location

Related Publications (16)

  • Shorvon PJ, McHugh S, Diamant NE, Somers S, Stevenson GW. Defecography in normal volunteers: results and implications. Gut. 1989 Dec;30(12):1737-49. doi: 10.1136/gut.30.12.1737.

    PMID: 2612988BACKGROUND
  • Kenton K, Shott S, Brubaker L. The anatomic and functional variability of rectoceles in women. Int Urogynecol J Pelvic Floor Dysfunct. 1999;10(2):96-9. doi: 10.1007/pl00004019.

    PMID: 10384970BACKGROUND
  • Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Functional constipation and outlet delay: a population-based study. Gastroenterology. 1993 Sep;105(3):781-90. doi: 10.1016/0016-5085(93)90896-k.

    PMID: 8359649BACKGROUND
  • Siproudhis L, Dautreme S, Ropert A, Briand H, Renet C, Beusnel C, Juguet F, Rabot AF, Bretagne JF, Gosselin M. Anismus and biofeedback: who benefits? Eur J Gastroenterol Hepatol. 1995 Jun;7(6):547-52.

    PMID: 7552638BACKGROUND
  • van Dam JH, Hop WC, Schouten WR. Analysis of patients with poor outcome of rectocele repair. Dis Colon Rectum. 2000 Nov;43(11):1556-60. doi: 10.1007/BF02236738.

    PMID: 11089592BACKGROUND
  • Fleshman JW, Fry RD, Kodner IJ. The surgical management of constipation. Baillieres Clin Gastroenterol. 1992 Mar;6(1):145-62. doi: 10.1016/0950-3528(92)90024-9.

    PMID: 1586766BACKGROUND
  • Altomare DF, Rinaldi M, Veglia A, Petrolino M, De Fazio M, Sallustio P. Combined perineal and endorectal repair of rectocele by circular stapler: a novel surgical technique. Dis Colon Rectum. 2002 Nov;45(11):1549-52. doi: 10.1007/s10350-004-6465-9.

    PMID: 12432306BACKGROUND
  • Dodi G, Pietroletti R, Milito G, Binda G, Pescatori M. Bleeding, incontinence, pain and constipation after STARR transanal double stapling rectotomy for obstructed defecation. Tech Coloproctol. 2003 Oct;7(3):148-53. doi: 10.1007/s10151-003-0026-4.

    PMID: 14628157BACKGROUND
  • Boccasanta P, Venturi M, Stuto A, Bottini C, Caviglia A, Carriero A, Mascagni D, Mauri R, Sofo L, Landolfi V. Stapled transanal rectal resection for outlet obstruction: a prospective, multicenter trial. Dis Colon Rectum. 2004 Aug;47(8):1285-96; discussion 1296-7. doi: 10.1007/s10350-004-0582-3.

    PMID: 15484341BACKGROUND
  • Boccasanta P, Venturi M, Salamina G, Cesana BM, Bernasconi F, Roviaro G. New trends in the surgical treatment of outlet obstruction: clinical and functional results of two novel transanal stapled techniques from a randomised controlled trial. Int J Colorectal Dis. 2004 Jul;19(4):359-69. doi: 10.1007/s00384-003-0572-2. Epub 2004 Mar 13.

    PMID: 15024596BACKGROUND
  • Pescatori M, Dodi G, Salafia C, Zbar AP. Rectovaginal fistula after double-stapled transanal rectotomy (STARR) for obstructed defaecation. Int J Colorectal Dis. 2005 Jan;20(1):83-5. doi: 10.1007/s00384-004-0658-5. Epub 2004 Sep 2. No abstract available.

    PMID: 15349740BACKGROUND
  • Grassi R, Romano S, Micera O, Fioroni C, Boller B. Radiographic findings of post-operative double stapled trans anal rectal resection (STARR) in patient with obstructed defecation syndrome (ODS). Eur J Radiol. 2005 Mar;53(3):410-6. doi: 10.1016/j.ejrad.2004.12.012.

    PMID: 15741014BACKGROUND
  • Mongardini M, Custureri F, Schillaci F, Cola A, Maturo A, Fanello G, Corelli S, Pappalardo G. [Prevention of post-operative pain and haemorrhage in PPH (Procedure for Prolapse and Hemorrhoids) and STARR (Stapled Trans-Anal Rectal Resection). Preliminary results in 261 cases]. G Chir. 2005 Apr;26(4):157-61. Italian.

    PMID: 16035252BACKGROUND
  • Binda GA, Pescatori M, Romano G. The dark side of double-stapled transanal rectal resection. Dis Colon Rectum. 2005 Sep;48(9):1830-1; author reply 1831-2. doi: 10.1007/s10350-005-0103-z. No abstract available.

    PMID: 15991070BACKGROUND
  • Jayne DG, Finan PJ. Stapled transanal rectal resection for obstructed defaecation and evidence-based practice. Br J Surg. 2005 Jul;92(7):793-4. doi: 10.1002/bjs.5092. No abstract available.

    PMID: 15962257BACKGROUND
  • Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ 3rd. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc. 1990 Nov;65(11):1456-79. doi: 10.1016/s0025-6196(12)62169-7.

    PMID: 2232900BACKGROUND

MeSH Terms

Conditions

RectoceleIntussusceptionConstipation

Condition Hierarchy (Ancestors)

Rectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsIntestinal ObstructionSigns and Symptoms, DigestiveSigns and Symptoms

Results Point of Contact

Title
Susan Knippenberg, Clinical Scientist
Organization
Ethicon Endo-Surgery

Study Officials

  • Robin F Scamuffa, MS

    Ethicon Endo-Surgery

    STUDY DIRECTOR
  • William Bernie, MD

    Ethicon Endo-Surgery

    STUDY DIRECTOR
  • Anthony J Senagore, MD

    Medical University of Ohio

    PRINCIPAL INVESTIGATOR
  • Anders F Mellgren, MD, PhD

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2005

First Posted

November 22, 2005

Study Start

October 1, 2005

Primary Completion

March 1, 2008

Study Completion

June 1, 2008

Last Updated

July 16, 2018

Results First Posted

April 7, 2011

Record last verified: 2017-10

Locations